Ownership

Tighe Reardon - Acting Chief Financial Officer at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Acting Chief Financial Officer
Stock Symbol: JANX on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Tighe Reardon - trading volume in the past year for Janux Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+850K	50.8%	$5.87	+$4.99M
Sells	-823K	49.2%	$54.75	-$45M
Net	+27.1K	1.6%		-$40.1M

Holdings reported by Tighe Reardon for Janux Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	3.34M	$183M	$54.75	Jun 3, 2024	By Avalon BioVentures SPV I, L.P.
Common Stock	634K	$34.7M	$54.75	Jun 3, 2024	By Avalon BioVentures I, LP
Common Stock	175K	$9.58M	$54.75	Jun 3, 2024	Direct
Stock Option (right to buy)	157K			Jan 2, 2024	Direct	Common Stock

Transactions reported by Tighe Reardon for Janux Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.